Back
OSXN
This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.
Osteopore Limited
🇦🇺 ASX
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual capital growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
2
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Osteopore Limited - Ordinary Fully Paid Deferred
📈 Performance
Price History
N/A
1M
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in OSXN
0
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in OSXN
N/A
OSXN investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
🙋 Legal gender of investors
Female
Male
Pearlers who invest in OSXN also invest in...
Osteopore Ltd. develops and markets bioresorbable polymer implants for neurosurgical, orthopaedic and maxillofacial surgeries. The Company’s commercialized products are designed to enable natural bone healing across multiple therapeutic areas. The Company’s patented technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. Through its proprietary manufacturing process, which uses a naturally dissolving polymer, its patented scaffolds enable bone tissue growth, significantly reducing the post-surgery complications commonly associated with permanent bone implants. The Company’s surgical specialty includes craniotomy, orbital floor reconstruction, socket preservation, cranioplasty patient-specific implants (PSI), craniosynostosis, guided bone regeneration, endoscopic transsphenoidal skull base surgery, burr hole restoration with the shunt drainage system, mandible PSI, and immediate implant loading, among others.
🙌 Performance (5Yr p.a)
-19.60%
📊 Share price
$0.01 AUD
🩺 HEALTH CARE
ETHI.AX was created on 2017-01-05 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to track the performance of an index (before fees and expenses) that includes a portfolio of large global stocks identified as Climate Leaders that have also passed screens to exclude companies with direct or significant exposure to fossil fuels or engaged in activities deemed inconsistent with responsible investment considerations.
🙌 Performance (5Yr p.a)
12.74%
📊 Share price
$16.24 AUD
🌏 GLOBAL
⛳️ DIVERSIFIED
📈 HIGH PRICE GROWTH
🤖 TECHNOLOGY
TECH.AX was created on 2017-04-06 by Global X. The fund's investment portfolio concentrates primarily on information technology equity. The ETF currently has 343.96m in AUM and 40 holdings. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the Morningstar Developed Markets Technology Moat Focus IndexSM (the Index).
🙌 Performance (5Yr p.a)
5.43%
📊 Share price
$104.85 AUD
🇦🇺 EX AUSTRALIA
🤖 TECHNOLOGY
💰 HIGH DIVIDEND
VEU.AX was created on 2009-05-12 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard All-World ex-US Shares Index ETF seeks to track the return of the FTSE All-World ex US Index before taking into account fees, expenses and tax
🙌 Performance (5Yr p.a)
10.31%
📊 Share price
$107.99 AUD
⛳️ DIVERSIFIED
📈 HIGH PRICE GROWTH
🌏 GLOBAL
VESG.AX was created on 2018-09-11 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Ethically Conscious International Shares Index ETF seeks to track the return of the FTSE Developed ex Australia Choice Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax
🙌 Performance (5Yr p.a)
17.99%
📊 Share price
$108.87 AUD
⛳️ DIVERSIFIED
🌏 GLOBAL
📈 HIGH PRICE GROWTH
🤖 TECHNOLOGY
Want more shares? Try these...